Onderzoeker
August Verbruggen
- Disciplines:Endocrinologie en metabole ziekten, Pediatrie en neonatologie, Verpleegkunde
Affiliaties
- Vakgroep Inwendige ziekten en Pediatrie (Departement)
Lid
Vanaf22 okt 2018 → 21 okt 2020 - Vakgroep Inwendige ziekten (Departement)
Lid
Vanaf1 okt 1993 → 30 sep 2018
Publicaties
1 - 10 van 69
- Etanercept in patients with inflammatory hand osteoarthritis (EHOA) : a multicentre, randomised, double-blind, placebo-controlled trial(2018)
Auteurs: Margreet Kloppenburg, Roberta Ramonda, Klaus Bobacz, Wing-Yee Kwok, Tom WJ Huizinga, Feline PB Kroon, Leonardo Punzi, Josef S Smolen, Bert Vander Cruyssen, Ron Wolterbeek, et al.
Pagina's: 1757 - 1764 - Immunoscintigraphic detection of tumour necrosis factor by radiolabelled certolizumab pegol in patients with erosive hand osteoarthritis : a proof-of-concept study(2018)
Auteurs: Bieke Lambert, Paulien Meersseman, August Verbruggen, Filip Van den Bosch
Pagina's: 310 - 311 - 99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients : a biodistribution and dosimetry study(2016)
Auteurs: Bieke Lambert, Filip Van den Bosch, August Verbruggen, Rudi Beyaert, Caroline Dumolyn, Filip De Vos
- Baseline scintigraphic detection of TNFa as a predictor of therapy response after treatment with certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients(2014)Volume: 66
Auteurs: Bieke Lambert, Filip De Vos, August Verbruggen, Filip Van den Bosch
Pagina's: S933 - S933 - 99mTc labelled S-HYNIC certolizumab pegol for selecting patients for anti-TNF alpha treatment: a biodistribution and dosimetric study(2013)Volume: 40
Auteurs: Bieke Lambert, Philippe Carron, Yves D'Asseler, Klaus Bacher, Filip Van den Bosch, Lennart Jans, Dirk Elewaut, August Verbruggen, Filip De Vos
Pagina's: S392 - S392 - Scintigraphic detection of TNF alpha with a radiolabeled anti-TNF alpha in patients with active peripheral spondyloarthritis and rheumatoid arthritis(2013)Volume: 65
Auteurs: Philippe Carron, Bieke Lambert, Filip De Vos, August Verbruggen, Dirk Elewaut, Filip Van den Bosch
Pagina's: S472 - S472 - Selecting patients with spondyloarthritis (SpA) or rheumatoid arthritis (RA) for antiTNF-alfa treatment: first scintigraphic data with Tc99m-labelled certolizumab pegol(2013)
Auteurs: Bieke Lambert, Filip Van den Bosch, August Verbruggen, Filip De Vos
Aantal pagina's: 1 - Second generation characterized chondrocyte implantation for the treatment of cartilage lesions in the knee(2012)Volume: 20
Auteurs: Aad Dhollander, Peter Verdonk, Stijn Lambrecht, René Verdonk, Dirk Elewaut, August Verbruggen, Karl Almqvist
Pagina's: S39 - S39 - CD34 and SMA expression of superficial zone cells in the normal and pathological human meniscus(2012)
Auteurs: Heidi Declercq, Ramses Forsyth, August Verbruggen, René Verdonk, Maria Cornelissen, Peter Verdonk
Pagina's: 800 - 808 - Impairment and impact of pain in female patients with Ehlers-Danlos syndrome: a comparative study with fibromyalgia and rheumatoid arthritis(2011)
Auteurs: Lies Rombaut, Fransiska Malfait, STEVEN RIMBAUT, August Verbruggen, Inge De Wandele
Pagina's: 1979 - 1987